Opaleye Management as of Dec. 31, 2016
Portfolio Holdings for Opaleye Management
Opaleye Management holds 40 positions in its portfolio as reported in the December 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Blueprint Medicines (BPMC) | 14.5 | $25M | 880k | 28.05 | |
| Axogen (AXGN) | 10.4 | $18M | 2.0M | 9.00 | |
| Ariad Pharmaceuticals | 7.3 | $12M | 1.0M | 12.44 | |
| Aevi Genomic | 4.6 | $7.8M | 1.5M | 5.18 | |
| Fibrogen (FGEN) | 4.2 | $7.1M | 330k | 21.40 | |
| Foamix Pharmaceuticals | 3.2 | $5.5M | 495k | 11.10 | |
| Agios Pharmaceuticals (AGIO) | 3.2 | $5.4M | 130k | 41.73 | |
| Codexis (CDXS) | 3.2 | $5.4M | 1.2M | 4.60 | |
| Chimerix (CMRX) | 3.2 | $5.4M | 1.2M | 4.60 | |
| Aquinox Pharmaceuticals | 3.0 | $5.1M | 310k | 16.51 | |
| Theravance Biopharma (TBPH) | 3.0 | $5.0M | 158k | 31.88 | |
| Momenta Pharmaceuticals | 2.9 | $5.0M | 330k | 15.05 | |
| Adamas Pharmaceuticals | 2.8 | $4.8M | 285k | 16.90 | |
| Cara Therapeutics (CARA) | 2.6 | $4.4M | 475k | 9.29 | |
| Prothena (PRTA) | 2.4 | $4.1M | 83k | 49.19 | |
| Loxo Oncology | 2.4 | $4.0M | 125k | 32.11 | |
| Eagle Pharmaceuticals (EGRX) | 2.3 | $4.0M | 50k | 79.34 | |
| Edge Therapeutics | 2.1 | $3.5M | 280k | 12.50 | |
| Macrogenics (MGNX) | 2.0 | $3.5M | 170k | 20.44 | |
| Xenon Pharmaceuticals (XENE) | 1.8 | $3.1M | 405k | 7.70 | |
| Enanta Pharmaceuticals (ENTA) | 1.8 | $3.0M | 90k | 33.50 | |
| Strongbridge Bioph shs usd | 1.6 | $2.8M | 1.2M | 2.40 | |
| Omeros Corporation (OMER) | 1.6 | $2.6M | 265k | 9.92 | |
| Clearside Biomedical (CLSD) | 1.4 | $2.4M | 270k | 8.94 | |
| Lion Biotechnologies | 1.2 | $2.1M | 300k | 6.95 | |
| Abeona Therapeutics | 1.1 | $1.9M | 400k | 4.85 | |
| Cytomx Therapeutics (CTMX) | 1.1 | $1.9M | 170k | 10.99 | |
| Proteostasis Therapeutics In | 1.1 | $1.8M | 150k | 12.26 | |
| Imprimis Pharmaceuticals | 1.1 | $1.8M | 720k | 2.50 | |
| Sage Therapeutics (SAGE) | 1.1 | $1.8M | 35k | 51.06 | |
| Neuroderm Ltd F | 1.0 | $1.7M | 115k | 15.05 | |
| Wafergen Bio-systems | 0.9 | $1.6M | 320k | 4.93 | |
| Corium Intl | 0.9 | $1.5M | 380k | 4.06 | |
| Sangamo Biosciences (SGMO) | 0.7 | $1.2M | 400k | 3.05 | |
| Achaogen | 0.6 | $1.0M | 80k | 13.01 | |
| Protalix Biotherapeutics Inc note 4.500% 9/1 | 0.5 | $869k | 1.9M | 0.45 | |
| Ocular Therapeutix (OCUL) | 0.5 | $783k | 94k | 8.37 | |
| Trillium Therapeutics, Inc. Cmn | 0.4 | $622k | 110k | 5.65 | |
| Biolinerx Ltd-spons | 0.1 | $230k | 250k | 0.92 | |
| Agile Therapeutics | 0.1 | $85k | 15k | 5.67 |
